BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34068827)

  • 1. A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes.
    Khin PP; Lee JH; Jun HS
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of β-cell identity and dedifferentiation, not an irreversible process?
    Patel S; Remedi MS
    Front Endocrinol (Lausanne); 2024; 15():1414447. PubMed ID: 38915897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-24 promotes pancreatic beta cells toward dedifferentiation to avoid endoplasmic reticulum stress-induced apoptosis.
    Zhu Y; Sun Y; Zhou Y; Zhang Y; Zhang T; Li Y; You W; Chang X; Yuan L; Han X
    J Mol Cell Biol; 2019 Sep; 11(9):747-760. PubMed ID: 30753517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions.
    Bensellam M; Jonas JC; Laybutt DR
    J Endocrinol; 2018 Feb; 236(2):R109-R143. PubMed ID: 29203573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death versus dedifferentiation: The molecular bases of beta cell mass reduction in type 2 diabetes.
    Sun T; Han X
    Semin Cell Dev Biol; 2020 Jul; 103():76-82. PubMed ID: 31831356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Cell compensation concomitant with adaptive endoplasmic reticulum stress and β-cell neogenesis in a diet-induced type 2 diabetes model.
    Huang H; Yang K; Wang R; Han WH; Kuny S; Zelmanovitz PH; Sauvé Y; Chan CB
    Appl Physiol Nutr Metab; 2019 Dec; 44(12):1355-1366. PubMed ID: 31082326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer.
    Wang Y; Ni Q; Sun J; Xu M; Xie J; Zhang J; Fang Y; Ning G; Wang Q
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31781763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans.
    Cinti F; Mezza T; Severi I; Suleiman M; Cefalo CMA; Sorice GP; Moffa S; Impronta F; Quero G; Alfieri S; Mari A; Pontecorvi A; Marselli L; Cinti S; Marchetti P; Giaccari A
    Metabolism; 2021 Jan; 114():154414. PubMed ID: 33129839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta cell dedifferentiation in type 1 diabetes: sacrificing function for survival?
    Webster KL; Mirmira RG
    Front Endocrinol (Lausanne); 2024; 15():1427723. PubMed ID: 38904049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes.
    Hasnain SZ; Prins JB; McGuckin MA
    J Mol Endocrinol; 2016 Feb; 56(2):R33-54. PubMed ID: 26576641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete Re-Expression of Neuroendocrine Progenitor/Stem Cell Markers is a Key Feature of β-Cell Dedifferentiation.
    Neelankal John A; Morahan G; Jiang FX
    J Neuroendocrinol; 2017 Jan; 29(1):. PubMed ID: 27891681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic β-cell identity in diabetes.
    Remedi MS; Emfinger C
    Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):110-6. PubMed ID: 27615139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular aspects of pancreatic β-cell dysfunction: Oxidative stress, microRNA, and long noncoding RNA.
    Saeedi Borujeni MJ; Esfandiary E; Baradaran A; Valiani A; Ghanadian M; Codoñer-Franch P; Basirat R; Alonso-Iglesias E; Mirzaei H; Yazdani A
    J Cell Physiol; 2019 Jun; 234(6):8411-8425. PubMed ID: 30565679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes.
    Moin ASM; Butler AE
    Curr Diab Rep; 2019 Aug; 19(9):83. PubMed ID: 31401713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in
    Ishida E; Kim-Muller JY; Accili D
    Diabetes; 2017 Aug; 66(8):2092-2101. PubMed ID: 28506962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-cell dedifferentiation in diabetes is important, but what is it?
    Weir GC; Aguayo-Mazzucato C; Bonner-Weir S
    Islets; 2013; 5(5):233-7. PubMed ID: 24356710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Beta Cell in Type 2 Diabetes.
    Christensen AA; Gannon M
    Curr Diab Rep; 2019 Aug; 19(9):81. PubMed ID: 31399863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.
    Talchai C; Xuan S; Lin HV; Sussel L; Accili D
    Cell; 2012 Sep; 150(6):1223-34. PubMed ID: 22980982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Anna Karenina Model of β-Cell Maturation in Development and Their Dedifferentiation in Type 1 and Type 2 Diabetes.
    Nimkulrat SD; Bernstein MN; Ni Z; Brown J; Kendziorski C; Blum B
    Diabetes; 2021 Sep; 70(9):2058-2066. PubMed ID: 34417264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Targeting of Endoplasmic Reticulum Stress in Pancreatic Beta Cells.
    Bilekova S; Sachs S; Lickert H
    Trends Pharmacol Sci; 2021 Feb; 42(2):85-95. PubMed ID: 33353789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.